Pfizer (NYSE:PFE) shares fell today on third-quarter results that came up short of the consensus revenue forecast.
The New York-based company posted profits of $2.2 billion, or 39¢ per share, on sales of $12.1 billion for the three months ended Sept. 30, 2020, for a -71.4% bottom-line slide on a sales decline of -4.3.
Adjusted to exclude one-time items, earnings per share were 72¢, 1¢ ahead of Wall Street, where analysts were looking for sales of $12.3 billion.
Get the full story at our sister site, Drug Discovery & Development.